Shikiar Asset Management Decreased Its Incyte (INCY) Stake by $5.73 Million; Cardinal Capital Management Increased Holding in Starwood Ppty Tr (STWD)

Incyte Corporation (NASDAQ:INCY) Logo

Cardinal Capital Management Llc increased its stake in Starwood Ppty Tr Inc (STWD) by 7.7% based on its latest 2018Q3 regulatory filing with the SEC. Cardinal Capital Management Llc bought 100,400 shares as the company’s stock declined 0.67% with the market. The institutional investor held 1.40 million shares of the consumer services company at the end of 2018Q3, valued at $30.22 million, up from 1.30M at the end of the previous reported quarter. Cardinal Capital Management Llc who had been investing in Starwood Ppty Tr Inc for a number of months, seems to be bullish on the $6.07B market cap company. The stock decreased 0.68% or $0.15 during the last trading session, reaching $22.04. About 2.02 million shares traded. Starwood Property Trust, Inc. (NYSE:STWD) has risen 2.58% since February 14, 2018 and is uptrending. It has outperformed by 2.58% the S&P500. Some Historical STWD News: 11/05/2018 – IWG PLC – CONFIRMS RECEIVED TWO SEPARATE INDICATIVE PROPOSALS FROM STARWOOD CAPITAL EUROPEAN OPERATIONS AND TDR CAPITAL LLP REGARDING POSSIBLE CASH OFFER; 03/05/2018 – STARWOOD CAPITAL GROUP TO SELL AN £830M ($1.1B) PORTFOLIO OF U; 27/03/2018 – FONCIERE DES REGIONS SA FDR.PA – CONFIRMS EXCLUSIVE-RIGHTS DISCUSSIONS ARE UNDERWAY WITH STARWOOD CAPITAL; 18/04/2018 – Starwood Capital Group Closes 11th Opportunistic Real Estate Fund At $7.55B; 18/04/2018 – STARWOOD CAPITAL GROUP OFFER PRICES ARE IN EUROS; 27/03/2018 – CA IMMO CAIV.Vl CFO SAYS NEED TO KNOW MORE ABOUT STARWOOD’S STRATEGY BEFORE CAN COMMENT ON ITS OFFER; 16/04/2018 – REG-STARWOOD EUROPEAN REAL ESTATE FINANCE LTD SWEF: DIVIDEND DECLARATION; 19/04/2018 – STARWOOD VP VISCIUS SAYS “A BIT OF FANTASY” BUILT INTO SHARE PRICES OF CA IMMO AND IMMOFINANZ, STARWOOD OFFERS FAIR; 09/04/2018 – Starwood Property at Non-Deal Roadshow Hosted By KBW Today; 01/05/2018 – Sternlicht’s Starwood Capital Is Said to Seek Sale of Apartments

Shikiar Asset Management Inc decreased its stake in Incyte (INCY) by 73.32% based on its latest 2018Q3 regulatory filing with the SEC. Shikiar Asset Management Inc sold 83,000 shares as the company’s stock declined 4.36% with the market. The institutional investor held 30,200 shares of the commercial physical & biological resarch company at the end of 2018Q3, valued at $2.09M, down from 113,200 at the end of the previous reported quarter. Shikiar Asset Management Inc who had been investing in Incyte for a number of months, seems to be less bullish one the $17.25B market cap company. The stock decreased 0.42% or $0.34 during the last trading session, reaching $81.06. About 1.38 million shares traded. Incyte Corporation (NASDAQ:INCY) has declined 31.01% since February 14, 2018 and is downtrending. It has underperformed by 31.01% the S&P500. Some Historical INCY News: 08/03/2018 – Bavarian Nordic Announces Phase 2 Trial Investigating Combination of Its Immunotherapy CV301 and Nivolumab in Microsatellite St; 18/04/2018 – Roche Gets FDA PMA Supplement for Cobas EGFR Mutation Test V2 to Be Used as Companion Diagnostic Test With Tagrisso; 30/04/2018 – FDA GRANTS PRIORITY REVIEW TO MERCK’S SBLA FOR KEYTRUDA®; 13/04/2018 – Opdivo (nivolumab), First PD-1 Inhibitor to Demonstrate Superior Survival Benefit Compared with Chemotherapy in a Predominantly Chinese Population with Previously Treated Non-Small Cell Lung Cancer (NSCLC); 13/03/2018 – FDA Grants Priority Review to Merck’s Supplemental Biologics License Application (sBLA) for KEYTRUDA® (pembrolizumab) for Treatment of Advanced Cervical Cancer; 06/04/2018 – Incyte and Merck Provide Update on Phase 3 Study of Epacadostat in Combination with KEYTRUDA® (pembrolizumab) in Patients with Unresectable or Metastatic Melanoma; 18/04/2018 – ROCHE -RECEIVED APPROVAL FROM FDA OF ITS PMA SUPPLEMENT FOR COBAS EGFR MUTATION TEST V2 TO BE USED AS COMPANION DIAGNOSTIC TEST WITH TAGRISSO; 16/05/2018 – Dynavax to Present New Data for SD-101 in Combination with KEYTRUDA® (pembrolizumab) at the 2018 American Society for Clinical Oncology Annual Meeting; 10/04/2018 – BerGenBio Completes Recruitment Into First Stage of Phase Il NSCLC Trial With Selective AXL Inhibitor Bemcentinib Combined With KEYTRUDA®; 06/04/2018 – The fallout over $INCY setback continues at $BMY and $NLNK, adding a note about NewLink program review in light of PhIII failure

Investors sentiment increased to 1.3 in 2018 Q3. Its up 0.22, from 1.08 in 2018Q2. It improved, as 26 investors sold STWD shares while 88 reduced holdings. 51 funds opened positions while 97 raised stakes. 162.60 million shares or 0.67% more from 161.51 million shares in 2018Q2 were reported. Carroll Associates owns 383 shares. Lpl Limited has invested 0.01% of its portfolio in Starwood Property Trust, Inc. (NYSE:STWD). Bessemer Grp invested in 0.16% or 2.01M shares. 9,604 are owned by Glenmede Commerce Na. Citadel Advisors Ltd Limited Liability Company invested in 38,633 shares or 0% of the stock. Price T Rowe Assoc Inc Md reported 0% stake. Waterfront Cap owns 400,400 shares. Morgan Stanley invested 0.04% in Starwood Property Trust, Inc. (NYSE:STWD). Royal Comml Bank Of Canada owns 1.07M shares for 0.01% of their portfolio. Principal Financial Group Inc Inc holds 0% or 26,808 shares. 80,234 are owned by Guggenheim Lc. Lodestar Inv Counsel Ltd Llc Il invested in 0.44% or 189,100 shares. Comerica Savings Bank holds 721,415 shares or 0.12% of its portfolio. Moreover, Ameriprise has 0.01% invested in Starwood Property Trust, Inc. (NYSE:STWD) for 1.11M shares. Barclays Pcl has 0.04% invested in Starwood Property Trust, Inc. (NYSE:STWD).

Among 12 analysts covering Starwood Property Trust Inc. (NYSE:STWD), 9 have Buy rating, 0 Sell and 3 Hold. Therefore 75% are positive. Starwood Property Trust Inc. had 29 analyst reports since August 5, 2015 according to SRatingsIntel. Keefe Bruyette & Woods maintained Starwood Property Trust, Inc. (NYSE:STWD) rating on Thursday, September 14. Keefe Bruyette & Woods has “Buy” rating and $24.0 target. Wells Fargo downgraded the shares of STWD in report on Wednesday, August 5 to “Market Perform” rating. Keefe Bruyette & Woods maintained Starwood Property Trust, Inc. (NYSE:STWD) rating on Monday, May 29. Keefe Bruyette & Woods has “Buy” rating and $2400 target. The firm has “Buy” rating by Compass Point given on Thursday, December 3. The rating was maintained by Deutsche Bank on Friday, August 7 with “Buy”. JMP Securities initiated the stock with “Outperform” rating in Tuesday, December 1 report. As per Tuesday, June 26, the company rating was maintained by FBR Capital. The company was downgraded on Thursday, December 15 by Bank of America. The stock has “Outperform” rating by FBR Capital on Tuesday, June 28. On Thursday, November 9 the stock rating was maintained by FBR Capital with “Buy”.

Cardinal Capital Management Llc, which manages about $1.96 billion and $3.18 billion US Long portfolio, decreased its stake in Calavo Growers Inc (NASDAQ:CVGW) by 49,726 shares to 461,029 shares, valued at $44.60 million in 2018Q3, according to the filing. It also reduced its holding in Pinnacle Foods Inc Del (NYSE:PF) by 11,638 shares in the quarter, leaving it with 499,189 shares, and cut its stake in Teledyne Technologies Inc (NYSE:TDY).

More notable recent Starwood Property Trust, Inc. (NYSE:STWD) news were published by: Seekingalpha.com which released: “KISS: Keep It Simple Starwood – Seeking Alpha” on July 02, 2018, also Seekingalpha.com with their article: “Starwood Property Trust: Why Smart Dividend Investors Buy The Drop – Seeking Alpha” published on August 09, 2018, Seekingalpha.com published: “Apple Hospitality REIT: Why I’m Not Taking A Bite Out Of This Apple – Seeking Alpha” on February 05, 2019. More interesting news about Starwood Property Trust, Inc. (NYSE:STWD) were released by: Seekingalpha.com and their article: “Why Not Buy This 8.7%-Yielding Commercial Mortgage REIT? – Seeking Alpha” published on November 11, 2018 as well as Seekingalpha.com‘s news article titled: “Starwood Property Trust: Strong Q1 Results And Cheap Valuation Scream For A Buy – Seeking Alpha” with publication date: May 05, 2018.

More notable recent Incyte Corporation (NASDAQ:INCY) news were published by: Nasdaq.com which released: “Report: Developing Opportunities within Incyte, Burlington Stores, Hannon Armstrong Sustainable Infrastructure Capital, iRobot, Lear, and Menlo Therapeutics — Future Expectations, Projections Moving into 2019 – Nasdaq” on January 29, 2019, also Nasdaq.com with their article: “Zacks.com featured highlights include: Incyte, First Majestic, Mattel and U.S. Silica – Nasdaq” published on February 12, 2019, Nasdaq.com published: “Market Close Report: NASDAQ Composite Index closes above 7000; up 117.91 points at 7,023.83 – Nasdaq” on January 15, 2019. More interesting news about Incyte Corporation (NASDAQ:INCY) were released by: Nasdaq.com and their article: “Tuesday Sector Leaders: Healthcare, Technology & Communications – Nasdaq” published on January 15, 2019 as well as Benzinga.com‘s news article titled: “10 Biggest Price Target Changes For Wednesday – Benzinga” with publication date: January 16, 2019.

Among 30 analysts covering Incyte (NASDAQ:INCY), 22 have Buy rating, 0 Sell and 8 Hold. Therefore 73% are positive. Incyte had 107 analyst reports since August 6, 2015 according to SRatingsIntel. RBC Capital Markets maintained Incyte Corporation (NASDAQ:INCY) on Wednesday, October 12 with “Outperform” rating. The stock of Incyte Corporation (NASDAQ:INCY) has “Market Outperform” rating given on Monday, October 10 by JMP Securities. Oppenheimer maintained it with “Hold” rating and $13500 target in Tuesday, July 25 report. Barclays Capital maintained Incyte Corporation (NASDAQ:INCY) on Wednesday, August 2 with “Overweight” rating. The firm earned “Hold” rating on Wednesday, July 5 by Oppenheimer. The stock of Incyte Corporation (NASDAQ:INCY) earned “Neutral” rating by UBS on Wednesday, January 16. The company was downgraded on Friday, April 6 by William Blair. As per Monday, January 23, the company rating was initiated by Credit Suisse. UBS maintained it with “Buy” rating and $130 target in Wednesday, August 5 report. On Wednesday, November 4 the stock rating was maintained by UBS with “Buy”.

Analysts await Incyte Corporation (NASDAQ:INCY) to report earnings on February, 21. They expect $0.31 earnings per share, up 1,450.00% or $0.29 from last year’s $0.02 per share. INCY’s profit will be $65.97 million for 65.37 P/E if the $0.31 EPS becomes a reality. After $0.20 actual earnings per share reported by Incyte Corporation for the previous quarter, Wall Street now forecasts 55.00% EPS growth.

Investors sentiment decreased to 1.19 in Q3 2018. Its down 0.04, from 1.23 in 2018Q2. It worsened, as 37 investors sold INCY shares while 125 reduced holdings. 66 funds opened positions while 126 raised stakes. 180.88 million shares or 1.39% less from 183.44 million shares in 2018Q2 were reported. Ancora Advsrs Ltd Liability Com reported 0% in Incyte Corporation (NASDAQ:INCY). Ameritas Inc reported 0.02% in Incyte Corporation (NASDAQ:INCY). Aqr Mngmt holds 131,826 shares or 0.01% of its portfolio. 32,856 were reported by State Of Alaska Department Of Revenue. Polar Llp reported 462,342 shares stake. North Star Asset holds 0.05% or 8,250 shares in its portfolio. Northern reported 1.91 million shares. Rhenman & Partners Asset Management has invested 2.61% in Incyte Corporation (NASDAQ:INCY). Qs Invsts Limited Liability Company has invested 0% in Incyte Corporation (NASDAQ:INCY). Tokio Marine Asset stated it has 50,242 shares or 0.61% of all its holdings. Susquehanna Gp Llp accumulated 136,954 shares. 7,032 were accumulated by Liberty Mutual Group Asset. Shine Inv Advisory, Colorado-based fund reported 70 shares. Retirement Of Alabama has invested 0.03% of its portfolio in Incyte Corporation (NASDAQ:INCY). Marshall Wace Limited Liability Partnership holds 0.02% or 36,209 shares.

Incyte Corporation (NASDAQ:INCY) Institutional Positions Chart